Case Western Reserve University / The University of Pennsylvania / State University / University Hospitals Case Medical Center / /
IndustryTerm
viral vector systems / potential applications / promising technology / lentiviral vector-based products / lentiviral vector technology / biotechnology / therapies for other diseases / owned biotechnology / THERAPY FOR BRAIN CANCER / /
MedicalCondition
leukemia / cancer / terrible disease / diseases / AIDS / brain cancer / hemophilia / glioblastoma / /
MedicalTreatment
stem cell therapy / CELL THERAPY / /
Organization
Ireland Cancer Center / State University / United States Army / Case Western Reserve School of Medicine / CASE WESTERN RESERVE UNIVERSITY / The University of Pennsylvania / University Hospitals Case Medical Center / /
Person
Anthony E. Pegg / Stanton L. Gerson / Tim Ravenscroft / Boro Dropulic / /
Position
CEO / director / president and chief scientific officer / Professor of Cellular / Professor of Hematological Oncology / /
NEWS RELEASE LENTIGEN CORPORATION ANNOUNCES EXCLUSIVE LICENSING AGREEMENT WITH CASE WESTERN RESERVE UNIVERSITY TO DEVELOP NOVEL STEM-CELL THERAPY FOR BRAIN CANCER Gaithersburg, MD (March 20, 2008) – Lentigen Corporati